Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis by Di Sante, Gabriele et al.
ORIGINAL RESEARCH
published: 17 August 2021
doi: 10.3389/fmed.2021.671018
Frontiers in Medicine | www.frontiersin.org 1 August 2021 | Volume 8 | Article 671018
Edited by:
João Eurico Fonseca,
University of Lisbon, Portugal
Reviewed by:
Cong-Qiu Chu,
Oregon Health and Science University,
United States
Richard Williams,
































This article was submitted to
Rheumatology,
a section of the journal
Frontiers in Medicine
Received: 22 February 2021
Accepted: 19 July 2021
Published: 17 August 2021
Haemophilus parasuis (Glaesserella
parasuis) as a Potential Driver of
Molecular Mimicry and Inflammation
in Rheumatoid Arthritis
Gabriele Di Sante 1†, Elisa Gremese 2,3†, Barbara Tolusso 2†, Paola Cattani 4,5,
Clara Di Mario 3, Simona Marchetti 4, Stefano Alivernini 2†, Maria Tredicine 1†,
Luca Petricca 2†, Ivana Palucci 4,5†, Chiara Camponeschi 1†, Virginia Aragon 6,
Andrea Gambotto 7,8,9†, Francesco Ria 1,4*† and Gianfranco Ferraccioli 10*†
1 Section of General Pathology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore,
Rome, Italy, 2Division of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli—IRCCS, Rome, Italy, 3Division
of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy, 4Dipartimento di Scienze di laboratorio e infettivologiche,
Fondazione Policlinico Universitario A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, 5Dipartimento
di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Sezione di Microbiologia, Università Cattolica
del S. Cuore, Rome, Italy, 6 Institut de Recerca i Tecnologies Agroalimentaries, Centre de Recerca en Sanitat Animal (CReSA,
IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, Spain, 7Department of Surgery, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States, 8Department of Molecular Genetics and Biochemistry,
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States, 9Department of Medicine, University of Pittsburgh
School of Medicine, Pittsburgh, PA, United States, 10Università Cattolica del Sacro Cuore, Rome, Italy
Background: Haemophilus parasuis (Hps; now Glaesserella parasuis) is an infectious
agent that causes severe arthritis in swines and shares sequence similarity with
residues 261–273 of collagen type 2 (Coll261−273), a possible autoantigen in rheumatoid
arthritis (RA).
Objectives/methods: We tested the presence of Hps sequencing 16S ribosomal
RNA in crevicular fluid, synovial fluids, and tissues in patients with arthritis (RA
and other peripheral arthritides) and in healthy controls. Moreover, we examined the
cross-recognition of Hps by Coll261−273-specific T cells in HLA-DRB1
∗04pos RA patients,
by T-cell receptor (TCR) beta chain spectratyping and T-cell phenotyping.
Results: Hps DNA was present in 57.4% of the tooth crevicular fluids of RA patients
and in 31.6% of controls. Anti-Hps IgM and IgG titers were detectable and correlated
with disease duration and the age of the patients. Peripheral blood mononuclear cells
(PBMCs) were stimulated with Hps virulence-associated trimeric autotransporter peptide
(VtaA10755−766), homologous to human Coll261−273 or co-cultured with live Hps. In both
conditions, the expanded TCR repertoire overlapped with Coll261−273 and led to the
production of IL-17.
Discussion: We show that the DNA of an infectious agent (Hps), not previously
described as pathogen in humans, is present in most patients with RA and that an Hps
peptide is able to activate T cells specific for Coll261−273, likely inducing or maintaining a
molecular mimicry mechanism.
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Conclusion: The cross-reactivity between VtaA10755−766 of a non-human infectious
agent and human Coll261−273 suggests an involvement in the pathogenesis of RA.
This mechanism appears emphasized in predisposed individuals, such as patients with
shared epitope.
Keywords: haemophilus (Glaesserella) parasuis, molecular mimicry, rheumatoid arthritis, host-pathogen
interaction, cross-reactivity
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease
of the joints that progressively destroys the cartilage and the
subchondral bone (1, 2). Susceptibility to RA is associated
with HLA-DRB1 locus (shared epitope) and antibodies against
citrullinated peptide (ACPA) (3–5), revealing a strict pathogenic
relationship between HLA class II-dependent immune response
(4, 6, 7) and the determinant role of T cells along with B cells in
this disease (8). Antibodies directed against citrullinated peptides
(fibrinogen, vimentin, enolase, collagen type II, etc.) can develop
years before the occurrence of the first symptoms (4, 9, 10),
highlighting the role that a slow adaptive autoreactive immune
response plays in driving disease occurrence.
One of the suspected autoantigens is the cartilage collagen
type 2, a major component of the target in inflammation. We
previously demonstrated that T cells characterized by specific
T-cell receptor (TCR) public clonotypes expanded in response
to collagen type 2 peptide 261–273 (Coll261−273) are specifically
expressed by RA patients compared to controls, are present
in the blood during the early active phase, disappear during
remission, and reoccur during relapses (11). These clonotypes
mostly use a restricted repertoire of variable beta (BV) chains
and we demonstrated that definite sequences of the TCR interact
with the autoantigen, most particularly the sequence CASSDTGS
SGAN (12, 13).
The autoantigen Coll261−273 shares sequence similarities
highly homologous to Capnocytophaga spp. (Cg) and
Streptococcus pyogenes (Spy), but especially to Haemophilus
parasuis (Hps; now Glaesserella parasuis); and since interesting
associations emerged between different infectious agents,
pathobionts or commensals, and RA (14), we tested in this study
the hypothesis that one or more infectious agents could break
down tolerance to self-components and may play a relevant role
in the pathogenesis of RA, through molecular mimicry (15, 16).
Abbreviations: Hps, Haemophilus parasuis; Pg, Porphyromonas gingivalis; Cg,
Capnocytophaga spp.; Spy, Streptococcus pyogenes; Coll261−273, peptide 261–273
of human type II collagen; VtaA, virulence-associated trimeric autotransporter;
PBMCs, peripheral blood mononuclear cells; TCR, T cell receptor; BV or vβ,
variable region of the beta chain of T cell receptor; BJ or jβ, junctional region of
the beta chain of T cell receptor; BC or cβ, constant region of the beta chain of T
cell receptor; HLA, histocompatibility leucocyte antigen; RA, rheumatoid arthritis;
UPIA, undifferentiated peripheral inflammatory arthritis; ERA, early rheumatoid
arthritis; LSRA, long-standing rheumatoid arthritis; HC, healthy control; PsA,
psoriatic arthritis; SpA, spondyloarthritis; JIA, juvenile idiopathic arthritis; DAS,
disease activity score; HAQ, health assessment questionnaire; RF, rheumatoid
factor; ACPA, anti-citrullinated protein antibodies; DMARDs, disease-modifying
antirheumatic drugs.
Peptide 755–766 from the protein VtaA10 (VtaA10755−766)
of Hps overlaps almost completely with Coll261−273, but to
date, no reports have shown an involvement of Hps in human
diseases. Hps is known to behave as a pathogen only in pigs
(17, 18). Intriguingly, in this animal,Hps causes Glässer’s disease,
characterized by severe arthritis (plus meningitis, pericarditis,
and polyserositis) with a poorly understood pathogenesis (19).
Despite a higher incidence of RA in a large group of Canadian
farmers being reported (20), to date, there are no other reports
indicating porkmeat consumption or farming as possible triggers
for RA (21, 22).
The data we present here show that Hps DNA can be found in
the gingival crevicular fluid of RA patients at a frequency higher
than in healthy controls (HCs > 30 years old), not different from
Young Healthy Controls (HCs <30 years old), in synovial fluid
and tissues. Public T-cell clonotypes specifically reacting with
the Coll261−273 peptide react with live Hps, cross-react with Hps
VtaA10755−766 and with live VtaA10
+ Hps, and produce IL-17
more often than IL-13 (11).
MATERIALS AND METHODS
Patients
A total of 100 consecutive patients with active arthritis at
the Division of Rheumatology of the Fondazione Policlinico
Universitario “A. Gemelli” I.R.C.C.S. of Rome have been
included in this study. The cohort is composed of 22 patients
with undifferentiated peripheral inflammatory arthritis (UPIA),
47 RA patients [all satisfying the 2010 American College
of Rheumatology (ACR) classification criteria] (23), and 31
patients with arthritides of different origins [ten with psoriatic
arthritis (PsA), four with systemic lupus erythematosus (SLE),
three with osteoarthritis (OA), three with juvenile idiopathic
arthritis (JIA), two with Reiter’s syndrome, two with polymyalgia
rheumatica, and one each with chondrocalcinosis, eosinophilic
fasciitis, gout, spondyloarthritis (SpA), villonodular synovitis,
Sjogren’s syndrome, and Still’s disease]. Demographic and clinical
characteristics are described in Table 1.
Thirty-eight aged healthy donors (>30 years old) and 131
young healthy donors (21–25 years old) were included in the
study also. The research follows the Declaration of Helsinki. The
ethical approval for the study was obtained from the Università
Cattolica del Sacro Cuore Ethical Committee. Informed written
consent was obtained from all the patients and healthy donors.
The available samples from enrolled patients were as
follows: (a) peripheral blood; (b) sub-gingival dental plaque
as previously described (24); and in 37 patients, also (c)
synovial tissues through an ultrasound-guided percutaneous
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TABLE 1 | Demographic, immunological, and clinical characteristics of patients with arthritides and healthy controls.
Characteristics RA UPIA Others p HS>30 HS<25
N 47 22 31 38 131
Age, (years) 56.4 ± 15.7 42.4 ± 14.0 40.8 ± 17.0 <0.001 49.4 ± 8.0 22.7 ± 1.5
Sex, no female, (%) 39 (83.0) 15 (68.2) 17 (63) 0.28 15 (75) 79 (60.3)
Age Onset, mean ± SD 51.4 ± 16.3 39.5 ± 14.8 35.9 ± 18.2 <0.001 N/A N/A
Disease Duration, (years) 5.0 ± 6.9 3.0 ± 4.0 4.9 ± 6.6 0.53 N/A N/A
BMI, mean number ± SD 24.8 ± 5.1 24.3 ± 4.2 24.2 ± 3.9 0.98 N/A N/A
Smokers, no (%) 13/42 (30.9) 7/20 (35.0) 6/27 (22.2) 0.32 Nd Nd
Ex-smokers, no (%) 8/42 (19.1) 2/20 (10.0) 5/27(18.5) 0.65 Nd Nd
Ab positive, no (%) 27 (57.4) 2 (9.1) 1 (3.2) <0.001 Nd Nd
ESR (mm/1 ∧ h) 54.1 ± 37.1 36.6 ± 36.3 39.0 ± 30.2 0.04 Nd Nd
CRP (mg/l) 26.2 ± 33.7 22.9 ± 33.3 24.8 ± 40.6 0.5 Nd Nd
DAS, score ± SD 3.5 ± 1.3 2.4 ± 0.7 N/A N/A N/A N/A
TJ44, mean number ± SD 10.3 ± 9.9 2.9 ± 3.2 N/A N/A N/A N/A
SJ44, mean number ± SD 7.7 ± 7.3 2.1 ± 1.4 N/A N/A N/A N/A
HAQ, mean number ± SD 1.3 ± 0.9 0.6 ± 0.7 N/A N/A N/A N/A
Values are mean ± standard deviation unless otherwise indicated. Ab positivity on the basis of at least a positivity for ACPA (anti-citrullinated peptide antibodies) and/or RF (rheumatoid
factor IgM and/or IgA); CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; DAS, disease activity score; TJ44, tender joints; SJ44, swollen joints; HAQ, health assessment
questionnaire (disability index); BMI, body Mass Index; Others, other arthritides; RA, rheumatoid arthritis; UPIA, undifferentiated peripheral inflammatory arthritis; Others arthritides:
patients affected by arthritis with different other diagnosis: 10 psoriatic arthritis (PsA), 1 chondrocalcinosis, 1 Eosinophilic Fasciitis, 1 Gout, 4 systemic lupus erythematosus (SLE), 1
spondylo-arthritis (SpA), 2 Reiter syndromes, 2 Polymyalgia Rheumatica, 1 villonodular Synovitis, 1 Sjögren Syndrome, 1 Still’s Disease, 3 Osteoarthritis (OA) and 3 Juvenile Idiopathic
Arthritis (JIA). SD, standard deviation. Statistical analyses are performed as described in methods. Significant differences are highlighted in bold displaying the p-values after ANOVA
analysis.
needle synovial biopsy (14G Tru-cut Precisa 1410—Hospital
Service) (25). Forty-seven RA [34 long-standing RA (LSRA)
and 13 early RA (ERA)] patients fulfilling at least six of
the ACR/European League Against Rheumatism (ACR/EULAR)
criteria for RA were considered as the case population.
All patients were typed for HLA-DRB1. Ten subjects were
tested by Immunoscope technique (26) (primers are listed in
Supplementary Table 1); they were all ERA and were being
treated following a standardized strategy (treat to target) in
an outpatient setting. RA patients with LSRA were excluded
from this latter analysis to avoid pharmacological treatment
diversity bias. Fifty out of 100 enrolled patients were tested for
IgG and IgM antibodies specific for Haemophilus parasuis as
described below.
Presence of Bacterial DNA in Crevicular
Fluids, Synovial Fluids, and Synovial
Tissues
Hps DNA was detected by polymerase chain reaction (PCR)
amplifying species-specific sequences on the 16S rRNA gene
proved useful for detection of Hps in clinical samples (27)
and following published protocols (28, 29). Similarly the
presence of Porphyromonas gingivalis (Pg) (30), S. pyogenes (Spy)
(31), and Capnocytophaga spp. (Cg) (32) DNA was detected
following protocols from the literature. Primers are listed in
Supplementary Table 1.
Antibody Response—ELISA
The complete passenger domain of a representative VtaA from
group 1 (VtaA9) and from group 2 (VtaA10) of the virulent
Nagasaki strain, together with the stalk, connector (amino acids
589–929, which contain the collagen domains of the protein),
and head fragments of VtaA10 were produced as recombinant
proteins as previously described (33). The recombinant VtaAs
and VtaA10 fragments were used to evaluate serum IgG and IgM
using an in-house ELISA. High-binding plates were coated with
0.5 µg/well of each of the five proteins and were subsequently
blocked with 5% skim milk. The sera were diluted 1:100 for
IgG and IgM detection. IgG antibodies were detected with a
horseradish peroxidase (HRP)-conjugated protein A and IgM
antibodies with an HRP-conjugated anti-human IgM. Positive
reactions were observed with the HRP substrate 3,3′,5,5-
tetramethylbenzidine. Similarly, an Hps bacterin was used in
ELISA to measure IgG and IgM using 1:500 and 1:100 dilution
of the sera, respectively.
To determine the presence and the concentrations of
IgG against type II collagen in the sera of patients, the
Human/Monkey Anti-Human type II Collagen IgG Antibody
Assay Kit was used following manufacturer’s instructions
(Chondrex, Woodinville, WA, USA). For each sample, patients
were scored positive if the optical density (OD) values in the
ELISA of anti-CII antibody concentration exceeded themeanOD
value by more than 3 standard deviations of controls. The data
were analyzed by linear regression analysis, assuming a Poisson
distribution. Frequencies were calculated from the slope of the
curves. Levels >95th percentile of controls (109 AU/mL) were
considered positive, as reported by Manivel et al. (34).
Sequence Analysis and Sequence
Similarity Searches
The genomic DNA samples positive for the Hps detection above
described (26 patients and 31 HCs) were sequenced for 16S
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gene, using BigDYE 3.1 and a Genetic Analyzer 3130 (Life
Technologies, Carlsbad, CA, USA).
For homology searches, we ran BLASTP (protein-protein
BLAST) against the Bacteria (taxid 2) database of the
National Center for Biotechnology Information (NCBI)
non-redundant protein (nr) GenBank CDS translations+
PDB+ SwissProt+ PIR+ PRF excluding environmental samples
from whole-genome sequencing (WGS) projects (146,243,064
sequences; 53,601,822,492 total letters). The 13aa sequence
AGFKGEQGPKGEP search parameters were adjusted to search
for a short input sequence (35).
CD4+ restricted Coll261−273 T-cell epitope AGFKGEQGPK
GEP was blasted against non-redundant protein sequences of
bacteria (taxid:2). The cutoff was determined by the identities,
positives, and presence of gaps.
Cell Cultures, Immunoscope, and
HLA-DRB1 Genotyping
Peripheral blood mononuclear cells (PBMCs) were collected
from 13 ERA patients in different phases of the disease
(Supplementary Table 2) and cultured as described in
our previous work (8, 11) in four different conditions: (i)
unstimulated or in the presence of: (ii) stimulation with
Coll261−273 (AGFKGEQGPKGEP) at a concentration of 20
mg/ml; (iii) VtaA10755−766 (AGPKGEQPKGE) at the same
concentration; or (iv) in co-culture with 106 CFU/well of
Hps ATCC R© 19417TM. In addition, PBMCs from two ERA
patients [one RA patient at his first remission of disease and
the second with moderate disease activity score (DAS)], after in
vitro stimulation with Coll261−273 or co-culture with Hps, were
enriched on the basis of the IL-17 or IL-13 secretion by MACS R©
secretion assay (Miltenyi Biotec, North Rhine-Westphalia,
Germany) (36).
In order to perform the analysis of the TCR repertoire,
we used the Immunoscope technique, a reverse transcriptase–
PCR (RT-PCR)-based method, which subdivides any bulk
population of T cells into approximately 2,400 categories
based upon different Vβ-Jβ gene combinations (37, 38).
DNA sample for Immunoscope was first amplified with
forward and reverse primers to the variable and constant
region segments, respectively (Supplementary Table 1). Next,
fluorescent primers to each of the joining segments were used
for “run-off” reactions. The Vβ, Cβ, and Jβ primers are listed
in Supplementary Table 1 (8, 11, 39). The “run-off” products
were then analyzed using a Genetic Analyzer and according
to nucleotide length fractioned in a spectrum with different
peaks, each of which represents a polyclonal T-cell population
sharing the same BV–junctional beta (BJ) rearrangement and
the same length of CDR3, but not the same sequence. A
Gaussian distribution of CDR3 lengths was observed in the
spectra in unstimulated samples. In contrast, clonal expansions
were observed as perturbations of the Gaussian or as the
presence of single peak, which represented an oligoclonal or
monoclonal T-cell population, respectively, not only sharing the
length of the CDR3 and the BV–BJ rearrangement but also
having a conserved CDR3 sequence. Sequencing of public TCRs
studied in this paper was performed and published in previous
works (11).
In addition, PBMCs from two ERA patients (both chosen as
proof of concept), after in vitro stimulation with Coll261−273 or
co-culture withHps, were enriched on the basis of the IL-17 or IL-
13 secretion by MACS R© secretion assay (Miltenyi). The presence
of specific TCRs was assessed on T cells that were allowed to
proliferate for 3 days in response to the peptide antigens or to
the co-culture.
HLA-DRB1 genotyping was performed using the INNO-
LiPA HLA-DRB1 plus kit (Fujirebio, Tokyo, Japan) following
manufacturer’s instructions.
Statistical Analysis
Data were analyzed using SPSS Statistics 22.0 (IBM, Armonk,
NY, USA) and Prism software 8.0 (GraphPad, San Diego, CA,
USA). Categorical and quantitative variables were recorded as
frequencies, percentage, and mean ± standard deviation (SD),
as appropriate. The non-parametric Mann–Whitney U-test was
used to compare the continuous variables. Categorical variables
were analyzed using χ2 test or Fisher’s exact test, as appropriate.
Spearman’s rank correlation was used to evaluate the relationship
between IgM bacterin, IgM VtaA9, and IgM VtaA10 levels and
demographic clinical parameters. p < 0.05 were considered
statistically significant.
RESULTS
Hps Is Detected at the Highest Frequency
in Young Healthy Patients, at the Lowest
Frequency in Older Healthy Controls, and
at Intermediate Frequency in Rheumatoid
Arthritis Patients
Clinical characteristics of RA patients, UPIA patients, and HCs
enrolled in this study are detailed in Table 1. RA patients had
a high disease activity and a high disability at the moment of
the biopsy [mean DAS 44 3.5 ± 1.4 (normal values <1.6), mean
HAQ-DI 1.3 ± 0.90 (normal values <0.5)]. Disease activity and
disability were higher in RA patients than in patients affected
by UPIA.
A total of 27 (57.4%) RA patients, two (9.1%) with UPIA and
one (3.2%) with other arthritides (one out the 10 affected by
PsA), were positive for at least one tested autoantibody [ACPA,
IgM rheumatoid factor (RF), and IgA RF]. The presence of joint
erosions was significantly higher in RA patients compared with
UPIA (63.3 vs. 25.0%, p = 0.01, data not shown) and compared
with patients affected by other arthritides (22.7%, all PsA, p <
0.01 vs. RA patients, data not shown). ERA patients had a lower
prevalence of erosions than patients with an LSRA (22.2 vs.
81.0%, p < 0.01, data not shown). Groups were comparable for
disease-modifying antirheumatic drugs (DMARDs) and steroid
therapy, although RA patients were more frequently receiving
biologic therapy (RA vs. other arthritides: p < 0.01, data
not shown).
We first assessed the presence of DNA from Hps, Pg, Cg, and
Spy in the crevicular fluids of 100 patients (Table 1). Results are
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summarized in Figures 1A,B, Supplementary Figure 1A, and
Supplementary Table 2.
Hps DNA was found in the crevicular fluids of 27 RA patients
(out of 47, 57.4%). In two ERA patients (out of 13 examined) it
was possible to find Hps DNA in the synovial tissues and fluids.
The frequency of positivity in the crevicular fluid of patients
suffering from other arthritides was similar to that observed in
RA (Figure 1A).
Given the loss of tolerance to self-antigens, which likely
happens several years before onset of autoimmune diseases such
as RA, our first step was to dissect the ability of Hps to infect
human subjects in two groups of healthy individuals defined as
“young” (<25 years) or “old” (>30 years) controls. The age of
this latter cohort was comparable with that of the group of RA
patients studied in this work. We found that Hps was present in
87 out of 131 medical students, males and females, between 21
and 25 years (66.4%), while only 12 out 38 (31.6%) crevicular
fluids still tested positive for Hps DNA (p < 0.0001, two-sided
Fisher’s exact test) in older HCs (>30 years). The comparison of
Hps positivity rates among age-matched controls and the groups
of patients revealed significant differences (HCs >30 vs. RA,
LSRA, UPIA, and other arthritides showed p-values of 0.028,
0.032, 0.029, and 0.038 respectively, two-sided Fisher’s exact test),
except for ERA patients (p= 0.2; Figure 1A).
We found that DNA of Pg was present in both young
and old controls (19.1 and 42.1%, respectively), while LSRA,
UPIA, and patients suffering from arthritis of other origin
had a frequency of positive results between 50 and 60%
(Supplementary Figure 1A). As previously described (30), ERA
patients showed a high frequency of positivity for Pg (90%),
significantly more than HCs >30 years (p= 0.002; Figure 1B).
DNA specific for Cg was present in all groups in the majority
of samples, while DNA of Spy was frequently positive only in
the LSRA group (Supplementary Figure 1A). We found that
only 10% of the patients had positive anti type 2 collagen
autoantibodies; clustering RA patients based on the presence of
Hps and Pg DNA (Figures 1A,B) and of antibodies specific for
type 2 collagen (10% of the cohort, Supplementary Figure 1B),
there were no significant differences in terms of disease severity,
age at onset, and seropositivity, although Hps+ RA patients
showed a trend of relatively low titers of ACPA, RF-IgM,
and IgA.
To confirm the positivity for Hps, we sequenced the DNA
obtained from crevicular fluid of 26 RA patients (among the
27 Hps positive, one sample from RA patient was missing
due to insufficiency for sequencing experiment) and 31 young
HCs positive for Hps. We obtained a sequence identity of
the 16S rRNA gene of Hps >95% as compared with the one
reported in the gene database in the NIH Public Library (11),
in 10 out of 26 patients and 13/31 young controls. In one
case, we found an identity of 100%. In most of the cases,
the missing identity of our sequence was concentrated in few
segments and was due to small nucleotide substitution as
summarized in Supplementary Table 3 and specifically shown in
Supplementary Table 4 and Supplementary Figure 2.
The Antibody Response to Hps in
Rheumatoid Arthritis and Undifferentiated
Peripheral Inflammatory Arthritis Patients
Microbe-specific antibodies to date represent a marker of the
individual history of infections (40). We therefore measured
the presence of IgM and IgG (for recent/chronic colonization)
specific for threeHps antigens, bacterin, VtaA9, and VtaA10. IgM
and IgG specific for VtaA9 andVtaA10 titers did not differ among
patients with RA or other arthritides (Supplementary Figure 3).
Within the RA group, the mean levels of anti-bacterin IgG
were consistently higher, though not statistically different, in the
subgroup of LSRA patients than in ERA patients (1.62 ± 0.52
vs. 1.17± 0.41, p= 0.53, Mann–Whitney U-test). No differences
were observed betweenHLA-DR1/HLA-DR4 positive or negative
RA patients (Supplementary Figure 4).
FIGURE 1 | Detection of 16S DNA for Hps and Pg in the crevicular fluid of patients and controls. Each bar represents the numbers of patients and healthy controls
positive for Pg (A) and Hps (B). Differences between proportions have been calculated with two-sided Fisher’s Exact test and significant p values are displayed among
groups. Hps DNA was detected by polymerase chain reaction (PCR) amplifying species-specific sequences on the 16S rRNA gene proved useful for detection of Hps
in clinical samples 21. The following primer’s pairs were used in a nested-PCR. Outer primers: Hps16S-forw 5′AGAGTTTGATCATGGCTCAGA3′ and Hps16S-rev
5′AGTCATGAATCATACCGTGGTA3′ 22; inner primers: Hps-forw 5′GTG ATG AGG AAG GGT GGT GT3′ and Hps-rev 5′GGC TTC GTC ACC CTC TGT3′ 23. The
predicted size of the final PCR product was 821 base pairs (bp). In order to detect the presence of Pg DNA were used 5′-AGG CAG CTT GCC ATA CTG CG-3′ and
5′-ACT GTT AGC AAC TAC CGA TGT-3′ oligonucleotides, for a 404 bp amplicon derived from the 16S rRNA.
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In RA patients, the amount of IgM specific for bacterin,
VtaA9, and VtaA10 unexpectedly increased with disease
duration; in UPIA patients, on the contrary, the amount of IgM
specific for bacterin and VtaA9 decreased with disease duration.
Thus, reinfections by Hpsmight play an active immunologic role
specifically in RA (Figures 2G–I).
Other correlations (Spearman’s rank correlations) were
observed between age at onset and specific anti-Hps IgM. We
found inverse correlations between age at onset of the RA patients
and antibody titers, such as bacterin-specific IgM (R = −0.55,
p = 0.01), VtaA9-specific IgM (R = −0.41, p = 0.05), and
close to significance for VtaA10-specific IgM (R = −0.40, p =
0.06; Figures 2A–C, respectively; Spearman’s rank correlations).
For VtaA9 IgM/IgG ratio (R = −0.4, p = 0.06, Spearman’s
rank correlation), the inverse correlation was not significant if
considered based on the age of the patients (Figures 2D–F).
Finally, Hps-specific IgG and IgM levels did not associate
to age or age at disease onset in UPIA patients (Figure 2 and
Supplementary Figure 5).
When examining the levels of IgM specific for VtaA10 as
a function of the age in non-RA patients, we observed that
the highest ones were found in subjects in their third decade
of life (Supplementary Figure 6). This observation indicated
that colonization and sero-conversion are more likely to occur
during the second/third decade of life, in most normal subjects.
This observation was consistent with the above-reported results
regarding the high frequency of detection of Hps DNA in
the cohort of young healthy subjects. Taken together, these
collected data indicate that infection by Hps appears to be a
common event.
A Large Fraction of T-Cell Receptors
Specific for huColl261–273 Cross-Recognize
VtaA10755–766 Also From Live Hps and
Produce IL-17A
In a search for epitopes of microbial origin potentially able to
sustain mimicry with human type 2 collagen, we found that
FIGURE 2 | Hps specific IgM titers and main correlations. Correlation between IgM titers specific for Bacterin, VtaA9, and VtaA10, specific for Hps, and Age at the
onset, Age, and disease duration from the sera of the RA (red circles) and UPIA (green triangles) patients. In RA IgM titers inversely correlate with age at onset (A,
bacterin, r = −0.55, p = 0.01. B, VtaA9, r = −0.41, p = 0.05. C, VtaA10, r = −0.40, p = 0.02), age (D, ns; p = 0.02. E, ns. F, ns), and directly correlate with the
disease duration (G, bacterin, r = 0.38, p = 0.07. H, ns. I, ns.). In UPIA patients IgM titers inversely correlate with the age at the onset (B, VtaA9, r = −0.60, p = 0.09)
and the age (E, VtaA9, r = −0.69, p = 0.04).
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peptide 755–766 from VtaA10 protein of Hps (a protein found
only in strains that are arthritogenic in swine) almost completely
overlapped with peptide 261–273 of human type 2 collagen that
comprises the dominant epitope for this protein in the HLA-
DRB1∗04 and 01. The only different residue between the two
sequences was residue Phe263 in collagen for residue Pro757
in VtaA10. This substitution affected the huColl261−273 peptide
anchor residue for DRB1∗04 binding pocket 1, according to our
previous work (12).
By using the Immunoscope technique, we previously
described several TCR beta-chains frequently used by
huColl261−273-specific T cells in DRB1
∗04 ERA patients
(8, 11). We therefore examined if these public T cells recognizing
huColl261−273 could also be stimulated by VtaA10755−766 and
by live Hps producing this protein, in a limited group of ERA
patients (n = 13, 7 of which were DRB1∗04+). The clinical and
demographic characteristics of these patients are described in
Supplementary Table 5. The presence and radiosensitivity index
(RSI) of T cells carrying the public TCRs were consistent with
those described in our previous papers (8, 11).
PBMCs from ERA patients were cultured without
antigen (background) or in the presence of Coll261−273, or
of VtaA10755−766 or with 10
6 CFU ofHps as previously described
(41). Immunoscope analysis was then performed on PBMCs, and
on enriched IL-13- or IL-17A-producing T cells upon antigen
stimulation, as previously described (11).
The stimulation with VtaA10755−766 was able to induce
proliferation of 12/28 (42.8%) T cells carrying the same TCRs
of those stimulated with Coll261−273, at the same peptide
concentration, in DRB1∗04pos RA patients (in only six out 26,
TCRs, 23.1%, in DRB1∗04neg patients). The actual availability
of an epitope also depends on the ability of APCs to generate
it from the protein and on the ability of bacteria to produce it
in sufficient amounts. Thus, it is relevant that collagen-specific
TCRs were stimulated by live VtaA10+ Hps even more frequently
(15/28, 53.6%) in DRB1∗04pos RA patients than VtaA10755−766,
as shown in Figure 3 and detailed in Supplementary Table 2. No
clonotype expansion was detectable in the other arthritides.
T cells obtained from two samples were also tested for their
ability to secrete IL-17A or IL-13 in response to stimulation
with Coll261−273 or live Hps. IL-17-secreting cells were detected
in both samples, but it appeared that T cells from the patient
in remission of disease (DAS 1.3) required bacterial (Hps)-
derived moieties to be induced to produce IL-17A (Figure 4A).
Coll261−273-specific TRBV25
+ IL-13+ T cells were detected in
only one of the two ERA patients (Figure 4B). Regarding the
other collagen-specific TCR rearrangements that we described
in our study, T cells carrying those TCRs appeared not to
secrete IL-17 or IL-13 under any type of antigen stimulation
(Supplementary Figures 7–10).
DISCUSSION
Here, we present data showing that an infectious agent not
previously described as pathogenic in humans, H. parasuis, now
G. parasuis, can trigger a pro-inflammatory response through
FIGURE 3 | Collagen261−273-specific, shared TCRs expand in response to
VtaA755−766 and to live VtaA10
+ Hps. Comparison of the results obtained by
Immunoscope analysis of TCR repertoire of the PBMC from 13 ERA patients of
whom demographic, immunological, and clinical characteristics are displayed
in Supplementary Table 4. PBMC were cultured in the following conditions:
without antigen (negative control), with Collagen261−273 (AGFKGEQPKGE) or
VtaA755−766 peptide (AGPKGEQPKGE) or co-cultured with Haemophilus
parasuis ATCC® 19417TM. Once obtained the TCR repertoire for each
condition (260 Vbeta-Jbeta rearrangements for each stimulation, data not
shown) we compared the VtaA755−766-specific and the live Hps-specific
repertoires with the Collagen261−273-specific one, all normalized for the
unstimulated cells repertoire. The white bars show the overlapping of TCR
repertoire after VtaA755−766 stimulation with the one after Collagen stimulation,
both normalized on the TCRs from unstimulated PBMC. With the black bars
the TCR repertoires are displayed comparing Hps co-culture with Collagen
stimulation. In DR4+ patients the overlap concerns a large part of the T cells
repertoires, much more than DR4 negative ERA patients.
molecular mimicry in RA, enhancing IL-17 production similarly
to Coll261−273 peptide in shared epitope-positive patients.
In swine, Hps infection can induce severe arthritis, thus
fulfilling the need to produce a similar disease in an animal
model (17, 18). Considering that some VtaAs are associated with
pathogenicity, an outcome leading to arthritis will depend on the
strain of Hps and the genetic background of infected individuals
in both pigs and humans.
We found that Hps frequently colonized crevicular fluid of
healthy subjects in their twenties. At an older age, however,
the detection rate of Hps DNA in the crevicular fluid of HCs
decreased, suggesting that a protective immune response may
have risen. Patients from all groups showed a high frequency
of positivity for Hps DNA in their crevicular fluid. However,
in light of a recent report identifying a close relative of Hps
in humans, Haemophilus massiliensis (42) and with our data
obtained with 16S rRNA gene sequence, we cannot completely
rule out that this close relative of Hps might alternatively be
present in some patients.
Comparing RA patients and HCs, we found no difference in
the frequency of Cg and Spy, whereas only Hps and Pg colonize
the oral mucosa more frequently, supporting the hypothesis that
the immunologic effect of an early first infection is associated
with rounds of re-stimulation with new infections.
Hps is able to stimulate autoreactive T cells specific for
Coll261−273 peptide, inducing IL-17A production in an HLA-
restricted manner. This agent may play a role as an inducer of
a self-reactivity through molecular mimicry. Molecular mimicry
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FIGURE 4 | Secretion of IL17A and IL13 by Vβ11-Jβ2.2 rearrangement from two DR4+ ERA patients after stimulation with Collagen and live Hps. PBMC samples
and sorted IL17 and IL13 secreting T cells from 2 ERA patients with different disease activity (DAS): (A) one in remission and (B) the other during active phase of
disease were compared through Immunoscope analysis. The presence of an antigen-specific expansion is displayed with a perturbation of the gaussian or the
presence of a single peak where possible the comparison could be done through the rate between the area of the same length peaks of two different samples (RSI,
rate stimulation index). Hps, Haemophilus (Glaesserella) Parasuis; CFU, Colony Forming Unit; IL17, Interleukin 17; IL13, Interleukin 13; VtaA, virulence-associated
trimeric autotransporter.
has been considered one of the mechanisms that initiate and
maintain autoimmunity (15, 43).
The group of T cells studied in this work meets the criteria for
pathogenicity. Previously, we demonstrated that T cells specific
for the autoantigenic Coll261−273 peptide are present in the
blood during the active phases of RA disappear during the
remission phases and reoccur at relapses (8). We have shown that
these (auto)reactive T cells use a restricted repertoire of TCRs
reproducibly committed in most patients, against autoantigen.
This TCR selection occurs in a DRB1-restricted manner, being
associated with those HLA alleles that are the strongest genetic
risk factors for RA, not in other arthritides. Finally, we have
shown that these TCRs (and, by extension, T cells) are found
in the synovial fluids of RA patients at onset of the disease.
Nevertheless, autoreactive T cells are present also in some DR4–
patients, where, although with a different conformation and a
different presentation, selected and expanded T-cell clones could
cross-react to human self-antigen(s).
Several candidates have been proposed as disease-promoting
microbes in RA, including viruses (44–48), mycobacteria (49–
51), and other bacteria (14, 52–56). Thus far, however, none have
been found as a candidate that could satisfy the criteria to be the
culprit of RA.
To date (57, 58), two bacteria, both linked to periodontitis,
have raised the greatest attention as being involved in RA
pathogenesis: (i) Pg, because of its property of using peptidyl
arginine-deiminase (PAD) to citrullinated proteins that become
antigenic (30); (ii) Aggregatibacter actinomycetemcomitans,
which may mimic membranolytic pathways by dysregulating the
activation of citrullinating enzymes in the host neutrophils and
trigger citrullination of autoantigen in RA joint(s) (14, 59).
We report here that a third infectious agent, Hps, carrying
VtaA, a family of outer membrane proteins involved in the
virulence process (60), contains an amino acidic sequence similar
to the most immunogenic sequence of Coll261−273. Hps triggers
the same T cells activated by the self-Coll261−273 and involved in
disease pathogenesis. These autoreactive T cells produce IL-17A
more often than IL-13 when stimulated by live Hps, contributing
to the synthesis of the cytokine most linked to the acute phase
of RA (61, 62). During disease, Hps persists in driving an active
immune response, as witnessed by the increased level of Hps-
specific IgM with disease duration.
Hps DNA was found in two synovial tissues, only from
RA patients. This observation indicates differences in the
pathogenesis of different arthritides. The acute presentation
of RA can be the result of an “individually determined”
autoimmune reaction, in which Hps may act as a (repeated)
trigger of autoreactive response, or by modifying trafficking (63,
64) and secretory properties, of self-collagen-specific T cells, as
illustrated in Figure 4B. However, in at least some cases, the acute
presentation of RAmay also be the result of an allo-(Hps)-specific
immune response toward chronic or relapsing joint colonization,
similar to what has been shown in other models (41).
The data reported in the present study suggest that VtaA10+
Hps colonization may play a role in the pathogenesis of RA,
where reinfections or persistent infections appear to maintain
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an immune-driven ability. If this hypothesis is confirmed, a
vaccination strategy using VtaA10- Hps in the first decade of
life and/or an accurate prevention of re-infections through (e.g.),
antibiotic clearance could open up new strategies for preventing
or improving the outcome of RA. Certainly, since only some RA
has been colonized, other agents may be involved (65).
In conclusion, Hps-induced molecular mimicry appears to
be involved in the pathogenesis of RA. The pathogenicity
of Hps in the animal model, the ability of the Hps epitope
VtaA10755−766 to stimulate the same T-cell clonotypes that react
to Coll261−273, the presence of Hps DNA in the crevicular
fluid of most RA patients (and in the synovial tissues and
fluids), and the presence of both IgM and IgG antibodies
to the collagen domains of VtaA10 prove Witebsky’s revised
criteria for autoimmune diseases (66). Prospective studies in
normal subjects carrying the DRB1∗04 allele and positive for
Hps should clarify how often and when subjects would develop
RA. The possibility that an infectious agent could be adequately
controlled by antibiotics or by vaccination might really change
the future of RA, as demonstrated in previous combination
studies (67, 68).
Further in vivo models might help to better understand
whether Hps infection alone or in combination with Pg may
actually lead to more arthritis, and studies in mice humanized
for collagen II, CD4, and HLADRB1∗04 will be needed to
determine whether Hps infection can lead to rheumatoid-like
arthritis (69).
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